The Pediatric/Adult Asthma Coalition of New Jersey is sponsored by the American Lung Association of the Mid-Atlantic. Although this document has been funded wholly or in part by the American Lung Association in New Jersey, it has not gone through the Agency’s publications review process and therefore, may not necessarily reflect the views of the Agency and no official endorsement should be inferred. Information in this publication is not intended to diagnose health problems or take the place of medical advice. For asthma or any medical condition, seek medical advice from your child’s or your health care professional.
The pharma consortium transformed from primarily an R&D outfit searching for substitutes for CFC-based inhalers into a lobbying group intent on eliminating the old inhalers. It set up shop in the K Street offices of Drinker Biddle, a major DC law firm. Between 2005 and 2010, it spent $520,000 on lobbying. (It probably spent even more; as a trade group, it’s not required to disclose all of its advocacy spending.) Meanwhile, IPAC lobbied for other countries to enact similar bans, arguing that CFC-based inhalers should be eliminated for environmental reasons and replaced with the new, HFC-based inhalers.
A version of this article appears in print on October 13, 2013, on page A 1 of the New York edition with the headline: The Soaring Cost of a Simple Breath. Get Free Email Alerts on These Topics Asthma Drugs (Pharmaceuticals) Prices (Fares, Fees and Rates) Series Inside Health » Too Hot to Handle Arts » The Harmony of Liberty Opinion » Should Beach Privatization Be Allowed? Room for Debate asks whether shorefront homeowners should have to open their land to all comers.